Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RemeGen Co. Ltd. Class H (HK:9995)
HKEX:9995
RemeGen Co. Ltd. Class H (9995) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
9995 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9995 Stock 12 Month Forecast
There Are No Analyst Ratings for HK:9995 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
9995 Financial Forecast
Detailed List of Analyst Forecasts
J.P. Morgan
HK$27→HK$28
Hold
31.15%
Upside
Reiterated
04/02/24
Remegen Co Ltd (9995:HK) PT Raised to HK$28 at JPMorganJPMorgan analyst Yang Huang raised the price target on Remegen Co Ltd (9995:HK) to HK$28.00 (from HK$27.00) while maintaining a Neutral rating.
CMB International Securities
HK$41.72
Buy
95.41%
Upside
Reiterated
04/02/24
We remain positive toward the guidance because: 1) sales of both have performed strongly YTD as per mgmt; 2) the newly added salesforce in 2023 may start to contribute significantly to sales in 2024; and 3) the inclusion of 300 new top-grade hospitals and 200 new top-grade hospitals in 2023 should boost product sales. We expect to experience an uptake in FY24, with RC18 taking a slight lead. Looking forward to next step of RC18’s global development. The first stage of RC18’s Ph3 global SLE trial has completed enrolment of 90 patients. RemeGen is internally discussing whether to unblind the first-stage study or keep it blinded as part of the second stage. The company expects to start enrolling for the second stage of the Ph3 study by mid-2024, which will be followed by another Ph3 study as required by the FDA.
CLSA
HK$30.2→HK$34.6
Buy
62.06%
Upside
Reiterated
03/31/24
Remegen Co Ltd (9995:HK) PT Raised to HK$34.60 at CLSACLSA analyst Matthew Yan raised the price target on Remegen Co Ltd (9995:HK) to HK$34.60 (from HK$30.20) while maintaining a Buy (1) rating.
Best Analysts Covering RemeGen Co. Ltd. Class H
Which Analyst Should I Follow If I Want to Buy HK:9995 and Sell After:
1 Month
3 Months
1 Year
Success Rate
0/3 ratings generated profit
Average Return
-34.40%
reiterated a buy rating 3 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -34.40% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
9995 Analyst Recommendation Trends
Rating
Oct 23
Nov 23
Jan 24
Mar 24
Apr 24
Strong Buy
1
1
0
0
1
Buy
0
2
2
2
0
Hold
1
1
2
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
4
4
4
4
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
9995 Stock Forecast FAQ
What is HK:9995’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:9995’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:9995, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RemeGen Co. Ltd. Class H a Buy, Sell or Hold?
Currently, no data Available
What is RemeGen Co. Ltd. Class H’s share price target?
Currently, no data Available
What do analysts say about RemeGen Co. Ltd. Class H?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of RemeGen Co. Ltd. Class H?
To buy shares of HK:9995, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.